Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Manufacturer
Device Type
FDA Class
Clinical Guidelines
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
The statement provides expanded indications for cardiac resynchronization therapy (CRT) in an effort to clarify which patients are most likely to benefit from CRT.
August 21, 2012
Guidelines & Protocols
CPT Guidance for Code Applications
August 1, 2012 – HRS frequently partners with the American College of Cardiology…
August 1, 2012
Clinical Guidelines
2012 HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection
The statement is the first of its kind to specifically address pacemaker device and mode selection, expanding upon the 2008 ACC/AHA/HRS Guidelines for Device-Based Therapy…
July 26, 2012
Clinical Guidelines
2012 PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern
The expert consensus statement provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a Wolff-Parkinson-White (WPW) electrocardiographic pattern.
May 10, 2012
Clinical Guidelines
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
The purpose of this expert consensus statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation.
March 5, 2012
Clinical Guidelines
Full Report from the First Annual Heart Rhythm Society Research Forum
The Heart Rhythm Society organized a research forum held on December 14–15, 2010, to develop a vision for future arrhythmia research and to design practical…
November 11, 2011
Clinical Guidelines
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
The impetus for the guidelines is based on an appreciation of the frequency of this clinical entity and a realization that many aspects of clinical…
November 8, 2011
Clinical Trials
The ARISTOTLE Trial
In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
September 15, 2011
Clinical Trials
The ROCKET AF Trial
In patients with atrial fibrillation, rivaroxaban (factor Xa inhibition) was noninferior to warfarin (vitamin K antagonists) for the prevention of stroke or systemic embolism.
September 8, 2011
Clinical Guidelines
2011 HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
The statement focuses primarily on the state of genetic testing for 13 distinct entities and the relative diagnostic, prognostic, and therapeutic impact of the genetic…
August 1, 2011